42
Participants
Start Date
June 30, 2011
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
Ipilimumab
This trial will investigate the addition of the anti-CTLA4 antibody ipilimumab to conventional carboplatin and etoposide chemotherapy in extensive stage small cell lung cancer.
Royal Bournemouth Hospital, Bournemouth
Leeds Teaching Hospitals NHS Foundation Trust, Leeds
Barts and The London NHS Trust, London
The Clatterbridge Cancer Centre NHS Foundation Trust, Metropolitan Borough of Wirral
Nottingham University Hospitals NHS Trust, Nottingham
Weston Park Clinical Trials Centre, Sheffield
Southampton University Hospitals NHS Trust, Southampton
Collaborators (2)
Cancer Research UK
OTHER
Institute of Cancer Research, United Kingdom
OTHER
Bristol-Myers Squibb
INDUSTRY
University Hospital Southampton NHS Foundation Trust
OTHER